Bank of New York Mellon’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,361
| Closed | -$164K | – | 4723 |
|
|
2022
Q1 | $164K | Hold |
4,361
| – | – | ﹤0.01% | 4298 |
|
|
2021
Q4 | $245K | Hold |
4,361
| – | – | ﹤0.01% | 4181 |
|
|
2021
Q3 | $315K | Hold |
4,361
| – | – | ﹤0.01% | 4012 |
|
|
2021
Q2 | $418K | Sell |
4,361
-1,784
| -29% | -$171K | ﹤0.01% | 3844 |
|
|
2021
Q1 | $909K | Sell |
6,145
-77
| -1% | -$11.4K | ﹤0.01% | 3382 |
|
|
2020
Q4 | $870K | Buy |
6,222
+1,652
| +36% | +$231K | ﹤0.01% | 3333 |
|
|
2020
Q3 | $694K | Buy |
4,570
+1,247
| +38% | +$189K | ﹤0.01% | 3326 |
|
|
2020
Q2 | $584K | Buy |
+3,323
| New | +$584K | ﹤0.01% | 3397 |
|
|
2019
Q1 | – | Sell |
-84
| Closed | -$3K | – | 4256 |
|
|
2018
Q4 | $3K | Sell |
84
-2
| -2% | -$71 | ﹤0.01% | 4216 |
|
|
2018
Q3 | $6K | Hold |
86
| – | – | ﹤0.01% | 4226 |
|
|
2018
Q2 | $7K | Sell |
86
-23
| -21% | -$1.87K | ﹤0.01% | 4192 |
|
|
2018
Q1 | $9K | Buy |
109
+23
| +27% | +$1.9K | ﹤0.01% | 4279 |
|
|
2017
Q4 | $64K | Hold |
86
| – | – | ﹤0.01% | 4150 |
|
|
2017
Q3 | $25K | Sell |
86
-8
| -9% | -$2.33K | ﹤0.01% | 4195 |
|
|
2017
Q2 | $24K | Buy |
94
+3
| +3% | +$766 | ﹤0.01% | 4216 |
|
|
2017
Q1 | $30K | Buy |
91
+7
| +8% | +$2.31K | ﹤0.01% | 4190 |
|
|
2016
Q4 | $50K | Sell |
84
-6
| -7% | -$3.57K | ﹤0.01% | 4128 |
|
|
2016
Q3 | $101K | Sell |
90
-60
| -40% | -$67.3K | ﹤0.01% | 4042 |
|
|
2016
Q2 | $164K | Buy |
150
+2
| +1% | +$2.19K | ﹤0.01% | 3948 |
|
|
2016
Q1 | $190K | Buy |
148
+43
| +41% | +$55.2K | ﹤0.01% | 3803 |
|
|
2015
Q4 | $258K | Buy |
105
+27
| +35% | +$66.3K | ﹤0.01% | 3763 |
|
|
2015
Q3 | $87K | Hold |
78
| – | – | ﹤0.01% | 4090 |
|
|
2015
Q2 | $79K | Sell |
78
-149
| -66% | -$151K | ﹤0.01% | 4082 |
|
|
2015
Q1 | $231K | Sell |
227
-17
| -7% | -$17.3K | ﹤0.01% | 3858 |
|
|
2014
Q4 | $815K | Buy |
244
+8
| +3% | +$26.7K | ﹤0.01% | 3413 |
|
|
2014
Q3 | $685K | Buy |
236
+26
| +12% | +$75.5K | ﹤0.01% | 3506 |
|
|
2014
Q2 | $799K | Buy |
+210
| New | +$799K | ﹤0.01% | 3424 |
|